Profil
Dag Nesse is currently the Vice President-Clinical Operations at Abliva AB. Previously, he held positions as the Director-Clinical Operations at EpiEndo Pharmaceuticals ehf, the Head-Clinical Operations at Modus Therapeutics AB, and the Head-Clinical Operations at Calliditas Therapeutics AB. Mr. Nesse completed his undergraduate studies at the University of Oslo and BI Norwegian Business School.
Aktiva positioner av Dag Nesse
| Företag | Position | Start |
|---|---|---|
| ABLIVA AB | Teknisk/Vetenskaplig/F&U Direktör | 2023-02-01 |
Tidigare kända positioner av Dag Nesse
| Företag | Position | Slut |
|---|---|---|
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Teknisk/Vetenskaplig/F&U Direktör | - |
| CALLIDITAS THERAPEUTICS AB | Teknisk/Vetenskaplig/F&U Direktör | - |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for chronic inflammatory diseases | Teknisk/Vetenskaplig/F&U Direktör | - |
Dag Nesses utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Abliva AB
Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BI Norwegian Business School
BI Norwegian Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
EpiEndo Pharmaceuticals ehf
EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for chronic inflammatory diseases | Health Technology |
















